Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Core Scientific, Inc./txCORZ · Entity 389 | See remarks | October 12, 2026 | October 14, 2026 |
| FLIR SYSTEMS INCFLIR · Entity 139418 | Sr VP, General Counsel and Sec | March 15, 2019 | March 18, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Core Scientific, Inc./tx
Report date October 12, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,159,668 |
Reported balance
After 2026-10-12 transaction · row 1
1 source rowRow 1 · 2026-10-12 · Sale · Disposed 10,000 · Balance 1,159,668 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.98 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 700,000 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 700,000 F3: Represents shares held by a grantor retained annuity trust of which the Reporting Person is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.98 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3: Represents shares held by a grantor retained annuity trust of which the Reporting Person is the sole trustee.
FLIR SYSTEMS INC
Report date March 15, 2019 · Filed March 18, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,526 |
Ending reported balance
After 2019-03-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-03-15 · Exercise / conversion · Acquired 5,000 · Balance 29,526 Row 2 · 2019-03-15 · Sale · Disposed 5,000 · Balance 24,526 |
| Non-Qualified Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.75 · Expires 2026-04-28 | Direct | 54,000 |
Reported balance
After 2019-03-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-15 · Exercise / conversion · Disposed 5,000 · Balance 54,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 14, 2026 20:07 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $15.12 | $151,160.00 |
DisclosureSEC source: 0000905148-26-004467 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,159,668 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.98 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:50 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $16.31 | $163,056.00 |
DisclosureSEC source: 0000905148-26-004398 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,169,668 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 21:05 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 8,228 | $15.98 | $131,483.44 |
DisclosureSEC source: 0000905148-26-004360 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,179,668 F1 · kind: This Form 4 reports the withholding of shares to satisfy withholding tax obligations upon the vesting of restricted stock units which were previously granted and reported. The change in share ownership of the Reporting Person reported in this Form 4 results from the difference between (i) the number of restricted stock units subject to vesting that were previously granted and reported and (ii) the net number of shares actually received upon vesting of such restricted stock units after the withholding of shares to satisfy withholding tax obligations. This does not reflect an open market sale of securities. Read SEC document |
| September 28, 2026 Filed Oct 1, 2026 00:40 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $16.76 | $167,586.00 |
DisclosureSEC source: 0000905148-26-004306 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,187,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.44 to $17.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:11 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $18.37 | $183,746.00 |
DisclosureSEC source: 0000905148-26-004258 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,197,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.81 to $18.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 20:01 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $17.14 | $171,362.00 |
DisclosureSEC source: 0000905148-26-004205 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,207,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.90 to $17.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:08 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GiftTranche 1 Warrants · Derivative | 95,000 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0000905148-26-004132 · form4.xml · derivative · entry 3 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,133 Underlying: Common Stock · 95,000 shares Expires 2027-01-23 F5 · kind: Reflects a charitable donation. F6 · derivative.exercise_date: Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:08 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $18.67 | $186,735.00 |
DisclosureSEC source: 0000905148-26-004132 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,217,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $19.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. F3 · balance_after: Reflects the transfer of 700,000 shares that the Reporting Person held directly to a grantor retained annuity trust of which the Reporting Person is the sole trustee on September 10, 2026, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $16.23 | $162,340.00 |
DisclosureSEC source: 0000905148-26-004062 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,927,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.02 to $16.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 24, 2026 Filed Aug 26, 2026 20:04 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $17.45 | $174,493.00 |
DisclosureSEC source: 0000905148-26-003935 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,937,896 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:05 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 11,205 | $20.13 | $225,556.65 |
DisclosureSEC source: 0000905148-26-003814 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,947,896 F3 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:05 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $20.10 | $200,974.00 |
DisclosureSEC source: 0000905148-26-003814 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,959,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.74 to $20.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,000 | $20.65 | $20,648.00 |
DisclosureSEC source: 0000905148-26-003595 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,969,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $20.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 9,000 | $19.90 | $179,087.40 |
DisclosureSEC source: 0000905148-26-003595 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,970,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.45 to $20.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 7,500 | $22.62 | $169,624.50 |
DisclosureSEC source: 0000905148-26-003481 · form4.xml · nonDerivative · entry 3 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,979,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.12 to $22.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,500 | $21.55 | $32,325.00 |
DisclosureSEC source: 0000905148-26-003481 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,986,601 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $21.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,000 | $20.39 | $20,390.30 |
DisclosureSEC source: 0000905148-26-003481 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,988,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.99 to $20.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 20:29 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 100 | $22.49 | $2,249.00 |
DisclosureSEC source: 0000905148-26-003381 · form4.xml · nonDerivative · entry 3 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,989,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 20:29 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,600 | $21.89 | $35,028.00 |
DisclosureSEC source: 0000905148-26-003381 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,989,201 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.47 to $22.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 20:29 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 8,300 | $20.75 | $172,199.27 |
DisclosureSEC source: 0000905148-26-003381 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,990,801 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.47 to $21.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 20, 2026 Filed Jul 22, 2026 20:10 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $22.30 | $222,995.00 |
DisclosureSEC source: 0000905148-26-003318 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,999,101 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.99 to $22.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 20:16 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 4,325 | $22.72 | $98,264.00 |
DisclosureSEC source: 0000905148-26-003287 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,009,101 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 21:41 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 300 | $23.01 | $6,903.00 |
DisclosureSEC source: 0000905148-26-003271 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,013,426 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.97 to $23.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 13, 2026 Filed Jul 15, 2026 21:41 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 9,700 | $22.43 | $217,571.97 |
DisclosureSEC source: 0000905148-26-003271 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,013,726 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.91 to $22.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:32 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $22.63 | $226,254.00 |
DisclosureSEC source: 0000905148-26-003185 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,023,426 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.24 to $23.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:17 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 5,469 | $25.59 | $139,951.71 |
DisclosureSEC source: 0000905148-26-003143 · form4.xml · nonDerivative · entry 4 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,033,426 F4 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:17 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 100 | $27.95 | $2,795.00 |
DisclosureSEC source: 0000905148-26-003143 · form4.xml · nonDerivative · entry 3 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,038,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:17 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,100 | $27.42 | $30,162.00 |
DisclosureSEC source: 0000905148-26-003143 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,038,995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.86 to $27.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:17 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 8,800 | $25.99 | $228,700.56 |
DisclosureSEC source: 0000905148-26-003143 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,040,095 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.56 to $26.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:02 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 2,400 | $29.88 | $71,700.96 |
DisclosureSEC source: 0000905148-26-003074 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,048,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.64 to $30.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:02 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 7,600 | $29.11 | $221,238.28 |
DisclosureSEC source: 0000905148-26-003074 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,051,295 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.61 to $29.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 100 | $28.79 | $2,879.00 |
DisclosureSEC source: 0000905148-26-002967 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,058,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 9,900 | $28.19 | $279,056.25 |
DisclosureSEC source: 0000905148-26-002967 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,058,995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.64 to $28.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:14 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 4,500 | $27.11 | $121,973.85 |
DisclosureSEC source: 0000905148-26-002877 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,068,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.97 to $27.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:14 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 5,500 | $26.64 | $146,506.80 |
DisclosureSEC source: 0000905148-26-002877 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,073,395 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.96 to $26.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 5,500 | $28.76 | $158,158.55 |
DisclosureSEC source: 0000905148-26-002803 · form4.xml · nonDerivative · entry 3 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,078,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.58 to $28.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 3,200 | $28.27 | $90,453.12 |
DisclosureSEC source: 0000905148-26-002803 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,084,395 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.57 to $28.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:09 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 1,300 | $26.93 | $35,007.05 |
DisclosureSEC source: 0000905148-26-002803 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,087,595 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.54 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $26.25 | $262,540.00 |
DisclosureSEC source: 0000905148-26-002726 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,088,895 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.81 to $26.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:13 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | GrantCommon Stock | 138,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002626 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,098,895 F1 · shares: Represents an annual restricted stock unit ("RSU") grant. One-third of the RSUs will vest on March 15, 2027, and the remaining two-thirds of the RSUs will vest in eight substantially equal quarterly installments thereafter, provided that the Reporting Person continues to provide service to the Issuer on each vesting date. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 400 | $23.76 | $9,503.00 |
DisclosureSEC source: 0000905148-26-002547 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,960,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.69 to $23.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:20 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 9,600 | $23.12 | $221,994.24 |
DisclosureSEC source: 0000905148-26-002547 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,960,748 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.66 to $23.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:06 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 7,400 | $23.39 | $173,097.84 |
DisclosureSEC source: 0000905148-26-002250 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,970,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.13 to $23.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:06 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 2,600 | $22.82 | $59,322.12 |
DisclosureSEC source: 0000905148-26-002250 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,977,748 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.13 to $23.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:15 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 100 | $21.53 | $2,153.00 |
DisclosureSEC source: 0000905148-26-002129 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,980,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:15 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 9,900 | $20.85 | $206,414.01 |
DisclosureSEC source: 0000905148-26-002129 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,980,448 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.49 to $21.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:02 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $20.94 | $209,390.00 |
DisclosureSEC source: 0000905148-26-001893 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,990,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.58 to $21.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 20:01 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 10,000 | $19.80 | $197,952.00 |
DisclosureSEC source: 0000905148-26-001779 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,000,348 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.53 to $20.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| April 16, 2026 Filed Apr 18, 2026 01:50 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | Tax withholdingCommon Stock | 16,741 | $19.08 | $319,418.28 |
DisclosureSEC source: 0000905148-26-001726 · form4.xml · nonDerivative · entry 1 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,010,348 F1 · kind: Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 20:02 UTC | Core Scientific, Inc./tx CORZ · Entity 389 | SaleCommon Stock | 400 | $18.99 | $7,597.00 |
DisclosureSEC source: 0000905148-26-001687 · form4.xml · nonDerivative · entry 2 DUCHENE TODD M · CIK 0001248745 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,027,089 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.97 to $19.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.